Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
665.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.301%)
Market Cap: £541.28m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Acquisition

2 Jun 2021 12:17

RNS Number : 6090A
Bloomsbury Publishing PLC
02 June 2021
 

BLOOMSBURY PUBLISHING PLC

("Bloomsbury" or "the Company")

Bloomsbury acquisition strengthens Consumer division: Acquisition of Head of Zeus Limited

 2 June 2021

Bloomsbury Publishing Plc (LSE: BMY), the leading independent publisher, today announces that it has completed the acquisition of the issued share capital of Head of Zeus Limited ("Head of Zeus", "HoZ" or the "Acquisition"). The total valuation is £8.45 million, including payments of pre-existing loans. The consideration, net of pre-existing loans, is £7.35 million, of which £5.5 million will be satisfied in cash at completion, with £1.1 million payable in cash post completion, subject to working capital and other considerations, and £0.75 million of deferred consideration payable in cash subject to achievement of revenue, profit and Netflix release targets.

Head of Zeus is an independent publisher of genre fiction and narrative non-fiction and children's books, based in London. It has published many bestsellers, won literary prizes and industry awards. Its best-selling authors include Dan Jones, Cixin Liu, Victoria Hislop, and Lesley Thomson, and Elodie Harper, whose The Wolf Den went last week to number 5 in The Times bestseller list. Cixin Liu's bestselling science fiction trilogy, The Three-Body Problem, is being adapted for Netflix by David Benioff and D.B. Weiss, creators of HBO's Game of Thrones.

This acquisition will provide a strong addition to Bloomsbury's thriving Consumer division and support our long term Consumer growth strategy, with new high quality authors and effective publishing across all formats, including e-book and audio.

HoZ generated £8.6 million* of revenue in the year ended 31 December 2020, and profit before tax of £0.3 million*, with net assets of £4.6 million*.

Nigel Newton, Chief Executive of Bloomsbury, commented:

"Head of Zeus's entrepreneurial and innovative approach to publishing, and its wide range of trade titles, will make a strong addition to Bloomsbury's own. Bloomsbury will be able to provide the scale and digital platforms to boost Head of Zeus' success while operating as an independent imprint within the Bloomsbury Consumer division. We look forward to welcoming Head of Zeus' great authors and talented staff to Bloomsbury and working with them in the years to come."

Anthony Cheetham, Chairman, Head of Zeus commented:

"After nine vigorous years as an independent publisher, I believe that Head of Zeus, our authors, our staff and our shareholders have found the right long term home for our company with Bloomsbury.

I have known Nigel Newton for more than thirty years. We share many of the same values: creative publishing, unique content and beautiful books. And an entrepreneurial spirit that values innovation above conformity. Bloomsbury Publishing Plc is itself unique as the only British book publisher listed on the London Stock Exchange.

I would like to express my gratitude to all our stakeholders for their support since Head of Zeus was launched in 2012, and my thanks to Bloomsbury for opening the door to further growth and opportunity in the years ahead."

*Audited.

 

For further information, please contact:

Bloomsbury Publishing Plc

 

Nigel Newton, Chief Executive

nigel.newton@bloomsbury.com

Penny Scott-Bayfield, Group Finance Director

penny.scott-bayfield@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Rebekah Chapman

bloomsbury@hudsonsandler.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

The information in this announcement has not been audited or otherwise independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. None of the Company or any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss whatsoever arising from any use of this announcement, or its contents, or otherwise arising in connection with this announcement.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares of the Company.

Certain statements, statistics and projections in this announcement are or may be forward looking. By their nature, forward‑looking statements involve a number of risks, uncertainties or assumptions that may or may not occur and actual results or events may differ materially from those expressed or implied by the forward-looking statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Accordingly, forward-looking statements contained in this announcement regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which are based on the knowledge and information available only at the date of this announcement's preparation.

The Company does not undertake any obligation to update or keep current the information contained in this announcement, including any forward‑looking statements, or to correct any inaccuracies which may become apparent and any opinions expressed in it are subject to change without notice.

References in this announcement to other reports or materials, such as a website address, have been provided to direct the reader to other sources of information on Bloomsbury Publishing Plc which may be of interest. Neither the content of Bloomsbury's website nor any website accessible by hyperlinks from Bloomsbury's website nor any additional materials contained or accessible thereon, are incorporated in, or form part of, this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUUAARAOUNRAR
Date   Source Headline
16th May 20087:00 amRNSInterim Management Statement
14th May 20089:06 amRNSDirector/PDMR Shareholding
25th Apr 20084:35 pmRNSDirector/PDMR Shareholding
24th Apr 20083:12 pmRNSDirector/PDMR Shareholding
10th Apr 20083:31 pmRNSHolding(s) in Company
1st Apr 20087:01 amRNSFinal Results
27th Mar 200810:40 amRNSDirector/PDMR Shareholding
11th Mar 200811:53 amRNSHolding(s) in Company
28th Feb 200812:06 pmRNSDirector/PDMR Shareholding
31st Jan 200810:22 amRNSDirector/PDMR Shareholding
22nd Jan 200811:20 amRNSAnnual Information Update
15th Jan 20087:01 amRNSTrading Statement
4th Jan 20085:06 pmRNSDealing by EBT
21st Dec 200711:30 amRNSDirector/PDMR Shareholding
19th Dec 200710:46 amRNSDirector/PDMR Shareholding
23rd Nov 20073:21 pmRNSDirector/PDMR Shareholding
19th Nov 20074:29 pmRNSBlocklisting Interim Review
11th Oct 200712:39 pmRNSHolding(s) in Company
9th Oct 20073:24 pmRNSHolding(s) in Company
8th Oct 20079:21 amRNSDirector/PDMR Shareholding
26th Sep 20074:43 pmRNSDirector appointment
26th Sep 20078:37 amRNSDirector/PDMR Shareholding
18th Sep 20077:02 amRNSInterim Results
10th Sep 20077:02 amRNSPublishing partnership
5th Sep 20072:08 pmRNSNotice of Results
5th Sep 20077:02 amRNSDirectorate Change
20th Aug 200711:50 amRNSHolding(s) in Company
13th Aug 20079:08 amRNSHolding(s) in Company
7th Aug 20079:58 amRNSHolding(s) in Company
3rd Aug 20072:30 pmRNSFinance Database Partnership
30th Jul 20077:01 amRNSDeathly Hallows
25th Jul 20075:14 pmRNSHolding(s) in Company
23rd Jul 20075:15 pmRNSFirst 24 hour sales
5th Jul 20075:51 pmRNSHolding(s) in Company
2nd Jul 20079:34 amRNSTotal Voting Rights
28th Jun 20071:28 pmRNSResult of AGM
28th Jun 20077:02 amRNSAGM Statement
18th Jun 20079:14 amRNSHolding(s) in Company
4th Jun 20075:08 pmRNSDirector/PDMR Shareholding
29th May 200710:39 amRNSNotice of AGM
18th May 200710:56 amRNSBlocklisting Interim Review
10th May 20075:26 pmRNSDirector/PDMR Shareholding
4th Apr 200711:52 amRNSDirector/PDMR Shareholding
3rd Apr 20077:02 amRNSFinal Results
30th Mar 200710:58 amRNSHolding(s) in Company
29th Mar 20078:54 amRNSHolding(s) in Company
9th Mar 200712:24 pmRNSHolding(s) in Company
6th Mar 20077:00 amRNSHolding(s) in Company
6th Mar 20077:00 amRNSHolding(s) in Company
16th Feb 20079:13 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.